41 – 50 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
- Contribution to journal › Debate/Note/Editorial
-
Mark
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S
- Contribution to journal › Article
-
Mark
Effect of late prophylaxis in hemophilia on joint status : A randomized trial
- Contribution to journal › Article
- 2016
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
- Contribution to journal › Article
-
Mark
Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.
- Contribution to journal › Article
-
Mark
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
- Contribution to journal › Article
-
Mark
Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia - a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
- Contribution to journal › Article
- 2015
-
Mark
Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.
- Contribution to journal › Article
-
Mark
Role of family history of venous thromboembolism (VTE) and thrombophilia as predictors of VTE recurrence: a prospective follow-up study.
- Contribution to journal › Article
-
Mark
Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.
- Contribution to journal › Article
